What is the latest price of clofazimine in 2024?

Clofazimine (Clofazimine) is an anti-leprosy drug, mainly used to treat leprosy, developed by the Swiss company Novartis. It is a red dye compound that was first synthesized in 1957 and began to be used for clinical treatment in the 1960s.

Clofazimine is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of about a few hundred yuan. Please consult the local hospital pharmacy for specific prices and medical insurance reimbursement. The cheaper ones abroad are Indian generic drugs. The price of 100mg*100 tablets is around 500 to 600, which is much cheaper than in China.

The anti-leprosy effect of clofazimine is mainly achieved by inhibiting the growth of Mycobacterium leprae. It inhibits bacterial growth and reproduction by binding to bacterial DNA and interfering with its replication and transcription processes. In addition, clofazimine also has anti-inflammatory effects and can reduce the inflammatory symptoms of patients in the reactive phase of leprosy.

Clofazimine is mainly used to treat leprosy, especially effective against multibacillary leprosy (MB leprosy). It is often used in combination with other anti-leprosy drugs, such as rifampicin and dapsone, to prevent the development of resistance. In addition, clofazimine can also be used to treat other infections caused by mycobacteria, such as non-tuberculous mycobacteriosis (NTM), and has certain effects on certain stubborn skin diseases (such as chronic eczema).

Clofazimine should be used strictly in accordance with the doctor's instructions during treatment, and avoid adjusting the dosage or stopping the medication on your own. Additionally, patients should avoid exposure to bright light, as clofazimine may increase sensitivity to sunlight and cause sunburn. In addition, pregnant and lactating women should use clofazimine with caution and under the advice of a doctor.